Cancer · 1975 · 13 citations · 20 references
MedicineCell BiologyOncologyCell ProliferationHematologic OncologyTumor ProgressionHematologic MalignanciesLymphoid NeoplasmsLymphoid TumorsMalignant NeoplasmsMalignant TumorsTumor Growth KineticsCell Proliferation IndicesCell Proliferation KineticsCellular ProliferationClinical RemissionGrowth FractionRelapsing Disease CourseTumor Cell ProliferationTumor Growth Rate
The kinetics of cell proliferation were studied in a patient with lymphosarcoma in a leukemic phase both before treatment when the disease was very advanced and again at the earliest sign of bone marrow relapse following a drug-induced remission. During advanced disease, the pulse 3H-TdR labeling index (LI) was 11%, the mitotic index (MI) was 0.4% the growth fraction (GF) was 0.6, and the generation time (TG), as measured by the median grain count halving time, was estimated to be 160 hours. The patient went into remission for 25 days after a short course of therapy with prednisolone and arabinosylcytosine (Ara-C). During early relapsing disease, the LI was 17%; MI, 1.1%; GF, 1.0; and TG, 85 hours. The results of this study suggest that the rate of cell proliferation slows in leukemia as the tumor mass increases in volume, and that the slower growth is due to an increase in cell generation time, a decrease in the growth fraction, and an increased rate of spontaneous cell loss.
20
Mortimer L. Mendelsohn · JNCI Journal of the National Cancer Institute · 1962 · 277 citations
Medicine, Cell Biology, Oncology +13
Cell loss as a factor in the growth rate of human tumours
G. Gordon Steel · European Journal of Cancer (1965) · 1967 · 277 citations
Medicine, Cancer Biology, Oncology +15
Acute myelocytic leukemia in adults
Bayard D. Clarkson · Cancer · 1972 · 138 citations · Full text
Medicine, Oncology, Pharmacology +15